These encouraging mouse results suggest that modified anthraxtoxin could be clinically viable, and this potent killer might someday be put to good use.
Objective:To find protective antigen(PA) defective mutants of anthraxtoxin with the same function as PA but with low immunogenicity, different domains of PA were mutated.
The Post-9/11 Anthrax Scare. Just days after the 2001 terror attacks, the Manhattan offices of ABC, NBC and CBS were jolted anew by the discovery of letters laced with the potentially deadly toxin.